Director, US CORE (Real-World Evidence & Epidemiology)

1w1 week ago

Genmab

Princeton, US · Full-time · $205,440 – $308,160

About this role

At Genmab, we develop antibody medicines that change lives and the future of cancer treatment. The Director, US CORE leads the US-focused CORE strategy for a defined therapeutic area. This role partners closely with US Medical Affairs, Market Access, Commercial, Global CORE, and RWE Analytics to generate evidence supporting product value and patient access.

The role collaborates with the US Field Health Evidence Outcomes Liaison team to ensure field readiness and address payer needs. It generates high-quality evidence for payer decision-making in the US healthcare environment. Daily work involves strategic oversight of studies and translation of insights into actionable plans.

Employees work in a compassionate, candid, and purposeful global workplace rooted in innovative science. Unique contributions drive solutions for patients, care partners, and families. The team brings big ambitions with care and fun to impactful work.

Join to lead US CORE strategy, inform global plans with market insights, and foster KOL relationships. Grow by representing on cross-functional teams and evaluating real-world data sources. Contribute to launch readiness and integrated evidence planning.

Requirements

Advanced degree in epidemiology, outcomes research, pharmacoepidemiology, or related field
Deep expertise in real-world evidence generation and US healthcare data sources
Strong knowledge of US payer, IDN, and population health decision-maker needs
Experience leading RWE strategies for therapeutic areas in oncology or serious diseases
Proven ability to partner with Medical Affairs, Market Access, and Commercial teams
Scientific rigor in study design, execution, and dissemination of CORE research
Skills in translating evidence for payer value communication and field tools
Established relationships with US KOLs in outcomes research and epidemiology

Responsibilities

Lead the development of the US CORE strategy and tactical plan aligned with US brand, medical, and market access priorities
Partner with Global CORE and external vendors to execute priority CORE studies for the US market
Leverage RWE to identify data-driven insights on unmet needs and disease burden
Represent US CORE on key cross-functional and global teams for evidence gap assessments and brand planning
Lead or participate in US payer or RWE advisory boards to gather evidence needs
Develop and maintain understanding of US payer, IDN, and population health evidence needs
Lead development of US payer-focused CORE value communication tools like field decks and AMCP Dossiers
Collaborate with Market Access Marketing to co-develop shared resources for HEOL